[HTML][HTML] Vascular dysfunction in Alzheimer's disease: a prelude to the pathological process or a consequence of it?

K Govindpani, LG McNamara, NR Smith… - Journal of clinical …, 2019 - mdpi.com
Alzheimer's disease (AD) is the most prevalent form of dementia. Despite decades of
research following several theoretical and clinical lines, all existing treatments for the …

[HTML][HTML] Dissecting the crosstalk between endothelial mitochondrial damage, vascular inflammation, and neurodegeneration in cerebral amyloid angiopathy and …

RM Parodi-Rullán, S Javadov, S Fossati - Cells, 2021 - mdpi.com
Alzheimer's disease (AD) is the most prevalent cause of dementia and is pathologically
characterized by the presence of parenchymal senile plaques composed of amyloid β (Aβ) …

[HTML][HTML] A review and hypothesized model of the mechanisms that underpin the relationship between inflammation and cognition in the elderly

M Tangestani Fard, C Stough - Frontiers in aging neuroscience, 2019 - frontiersin.org
Age is associated with increased risk for several disorders including dementias,
cardiovascular disease, atherosclerosis, obesity, and diabetes. Age is also associated with …

[PDF][PDF] Cerebral microvascular injury: a potentially treatable endophenotype of traumatic brain injury-induced neurodegeneration

DK Sandsmark, A Bashir, CL Wellington… - Neuron, 2019 - cell.com
Traumatic brain injury (TBI) is one the most common human afflictions, contributing to long-
term disability in survivors. Emerging data indicate that functional improvement or …

[HTML][HTML] Thrombin, a mediator of coagulation, inflammation, and neurotoxicity at the neurovascular interface: implications for Alzheimer's disease

J Iannucci, W Renehan, P Grammas - Frontiers in neuroscience, 2020 - frontiersin.org
The societal burden of Alzheimer's disease (AD) is staggering, with current estimates
suggesting that 50 million people world-wide have AD. Identification of new therapeutic …

[HTML][HTML] Decreased levels of circulating trimethylamine N-oxide alleviate cognitive and pathological deterioration in transgenic mice: a potential therapeutic approach …

Q Gao, Y Wang, X Wang, S Fu, X Zhang… - Aging (Albany NY …, 2019 - ncbi.nlm.nih.gov
Abstract Trimethylamine-N-oxide (TMAO), a metabolite of gut microbiota, has been
implicated in the pathogenesis of Alzheimer's disease (AD). However, the mechanisms by …

The role of trimethylamine‐N‐Oxide in the development of Alzheimer's disease

N Buawangpong, K Pinyopornpanish… - Journal of cellular …, 2022 - Wiley Online Library
Alzheimer's disease is associated with multiple risk factors and is the most common type of
dementia. Trimethylamine‐N‐oxide (TMAO), a gut microbiota metabolite derived from …

[HTML][HTML] Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy

M Merlini, D Wanner, RM Nitsch - Acta neuropathologica, 2016 - Springer
Alzheimer's disease (AD) is characterised by pathologic cerebrovascular remodelling.
Whether this occurs already before disease onset, as may be indicated by early Braak tau …

Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'

TM Hughes, S Craft, OL Lopez - Neurodegenerative disease …, 2015 - Future Medicine
Arterial stiffness is emerging as an important risk marker for poor brain aging and dementia
through its associations with cerebral small vessel disease, stroke, β-amyloid deposition …

[PDF][PDF] Identification of risk genes for Alzheimer's disease by gene embedding

Y Lagisetty, T Bourquard, I Al-Ramahi, CG Mangleburg… - Cell genomics, 2022 - cell.com
Most disease-gene association methods do not account for gene-gene interactions, even
though these play a crucial role in complex, polygenic diseases like Alzheimer's disease …